A Study of JNJ-70075200 in Healthy Participants

NCT04782661 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Program terminated prior to enrolling subjects

Conditions

Healthy

Interventions

DRUG: JNJ-70075200
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC